Furthermore, MGO may exert its effects via modification of important hormonal and enzymatic targets, such as insulin and its signaling components (causing insulin resistance), AMPK (amplifying anabolic processes), as well as collagen (leading to fibrosis/cirrhosis through ECM dysfunction). This evidence concerns the gene INS and Insulin resistance.